Dexmedetomidine Market Reaches $411M — The ICU Sedation Drug Quietly Transforming Critical Care
The global pharmaceutical grade dexmedetomidine hydrochloride market size was valued at USD 262 million in 2025. The market is projected to grow from USD 280 million in 2026 to USD 411 million by 2034, exhibiting a CAGR of 6.8% during the forecast period.
Pharmaceutical grade dexmedetomidine hydrochloride is a highly selective alpha-2 adrenergic receptor agonist used primarily for...